| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 2 982-992, Copyright © 1995 by American Association of Immunologists
ARTICLES |
S Markovic-Plese, H Fukaura, J Zhang, A al-Sabbagh, S Southwood, A Sette, VK Kuchroo and DA Hafler
Laboratory of Molecular Immunology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
We investigated the immune response to proteolipid protein (PLP), the most abundant central nervous system myelin protein in humans. A total of 8207 short-term T cell lines were generated from 49 individuals, 39 patients with multiple sclerosis and 10 control subjects. As we have reported previously, the frequency of PLP-reactive T cells did not differ between the two groups. To determine immunodominant PLP epitopes, proliferative responses of 971 PLP-specific lines were tested with 27 overlapping 20-amino acid peptides encompassing the human PLP sequence and the binding affinities of the PLP peptides to DRB5*0101 and DRB1*1501, DR2 MHC class II isotypes associated with multiple sclerosis, were determined. The T cell response after primary PLP stimulation was focused on two immunodominant epitopes comprising residues p30-49 and p180-199. These two fragments were recognized after processing of native protein by APCs and were situated in hydrophilic regions of PLP exhibiting only moderate affinity to DR2 molecules. In contrast, when T cells from DR2+ subjects were stimulated initially by individual synthetic peptides with either high or low affinity to DRB5*0101 and DRB1*1501 isotypes, additional cryptic epitopes were recognized. MHC restriction of lines specific for the cryptic PLP epitopes were related to binding affinity to DR2 isotypes. Our results indicate that protein Ags are recognized in vivo as immunodominant epitopes after Ag processing by APCs and as cryptic epitopes after processing, presumably by extracellular proteolytic enzymes.
This article has been cited by other articles:
|
|
 |
|
  J. M. Greer, P. A. Csurhes, D. M. Muller, and M. P. Pender Correlation of Blood T Cell and Antibody Reactivity to Myelin Proteins with HLA Type and Lesion Localization in Multiple Sclerosis J. Immunol., May 1, 2008; 180(9): 6402 - 6410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Takase, C.-R. Yu, R. M. Mahdi, D. C. Douek, G. B. DiRusso, F. M. Midgley, R. Dogra, G. Allende, E. Rosenkranz, A. Pugliese, et al. Thymic expression of peripheral tissue antigens in humans: a remarkable variability among individuals Int. Immunol., August 1, 2005; 17(8): 1131 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tangri, B. R. Mothe, J. Eisenbraun, J. Sidney, S. Southwood, K. Briggs, J. Zinckgraf, P. Bilsel, M. Newman, R. Chesnut, et al. Rationally Engineered Therapeutic Proteins with Reduced Immunogenicity J. Immunol., March 15, 2005; 174(6): 3187 - 3196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. H. Stern, Z. Illes, J. Reddy, D. B. Keskin, M. Fridkis-Hareli, V. K. Kuchroo, and J. L. Strominger Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis PNAS, February 1, 2005; 102(5): 1620 - 1625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. C. Q. Zang, S. Li, V. M. Rivera, J. Hong, R. R. Robinson, W. T. Breitbach, J. Killian, and J. Z. Zhang Increased CD8+ Cytotoxic T Cell Responses to Myelin Basic Protein in Multiple Sclerosis J. Immunol., April 15, 2004; 172(8): 5120 - 5127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bielekova, M.-H. Sung, N. Kadom, R. Simon, H. McFarland, and R. Martin Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+ T Cells in Multiple Sclerosis J. Immunol., March 15, 2004; 172(6): 3893 - 3904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S P Yentur, G Akman-Demir, M Eraksoy, and G Saruhan-Direskeneli Autoreactivity to myelin antigens related to HLA associations with multiple sclerosis Multiple Sclerosis, August 1, 2002; 8(4): 278 - 283. [Abstract] [PDF]
|
|
|
|
|
|
S. Winer, I. Astsaturov, R. K. Cheung, L. Gunaratnam, V. Kubiak, M. A. Cortez, M. Moscarello, P. W. O'Connor, C. McKerlie, D. J. Becker, et al. Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis J. Immunol., February 15, 2001; 166(4): 2831 - 2841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Tejada-Simon, Y. C. Q. Zang, D. Yang, J. Hong, S. Li, R. A. K. Singh, E. Van den Berg-Loonen, J. M. Killian, V. M. Rivera, and J. Z. Zhang Aberrant T cell responses to myelin antigens during clinical exacerbation in patients with multiple sclerosis Int. Immunol., December 1, 2000; 12(12): 1641 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Pender, P. A. Csurhes, J. M. Greer, P. D. Mowat, R. D. Henderson, K. D. Cameron, D. M. Purdie, P. A. McCombe, and M. F. Good Surges of Increased T Cell Reactivity to an Encephalitogenic Region of Myelin Proteolipid Protein Occur More Often in Patients with Multiple Sclerosis Than in Healthy Subjects J. Immunol., November 1, 2000; 165(9): 5322 - 5331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K G Warren and I. Catz Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP85VVHFFKNIVTP96RT in multiple sclerosis patients Multiple Sclerosis, October 1, 2000; 6(5): 300 - 311. [Abstract] [PDF]
|
|
|
|
|
|
C. M. Pelfrey, R. A. Rudick, A. C. Cotleur, J.-C. Lee, M. Tary-Lehmann, and P. V. Lehmann Quantification of Self-Recognition in Multiple Sclerosis by Single-Cell Analysis of Cytokine Production J. Immunol., August 1, 2000; 165(3): 1641 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Holz, B. Bielekova, R. Martin, and M. B. A. Oldstone Myelin-Associated Oligodendrocytic Basic Protein: Identification of an Encephalitogenic Epitope and Association with Multiple Sclerosis J. Immunol., January 15, 2000; 164(2): 1103 - 1109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Stevens, K. Chen, R. S. Seitz, E. E. Sercarz, and J. M. Bronstein Oligodendrocyte-Specific Protein Peptides Induce Experimental Autoimmune Encephalomyelitis in SJL/J Mice J. Immunol., June 15, 1999; 162(12): 7501 - 7509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schmidt Candidate autoantigens in multiple sclerosis Multiple Sclerosis, June 1, 1999; 5(3): 147 - 160. [Abstract] [PDF]
|
|
|
|
 |
|
 V. K. Tuohy, M. Yu, L. Yin, J. A. Kawczak, and R. Philip Kinkel Spontaneous Regression of Primary Autoreactivity during Chronic Progression of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis J. Exp. Med., April 5, 1999; 189(7): 1033 - 1042. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
